GGrantIndex
Sort

11,323 grants matching glioblastoma

Understanding and Preventing Tumor Disperal with Hydrogel Therapeutics

$335,799
Richard A Gemeinhart · University Of Illinois At Chicago · R01 · FY2007 · NS

Reversal of CMV-specific immune deficits in patients with glioblastoma

$335,793
Duane A. Mitchell · Duke University · R01 · FY2010 · NS

Epigenetic Modulation of Wnt/Beta-catenin Pathway and Tumorigenesis of Glioma Cells by KDM4C

$335,746
Suyun Huang · Virginia Commonwealth University · R01 · FY2019 · CA

Signal Integration of Transcriptional Pathways in Gliomagenesis

$335,709
Suyun Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Signal Integration of Transcriptional Pathways in Gliomagenesis

$335,709
Suyun Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA

Blood Flow MRI for Monitoring Glioma Angiogenesis

$335,708
David Charles Alsop · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA

Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma

$335,679
Joya Chandra · University Of Tx Md Anderson Can Ctr · R33 · FY2020 · NS

Inhibition of glioma tumor growth by antisense MMP-9

$335,673
Jasti S Rao · University Of Illinois At Chicago · R01 · FY2010 · NS

Epigenetic modulation of cellular aging to improve CAR-T therapy for solid tumors

$335,648
Benedetta Nicolis Di Robilant · Dorian Therapeutics, Inc. · R43 · FY2021 · CA

Regulation of Microtubule Dynamics and Organization During Cell Division

$335,588
Ryoma Ohi · Vanderbilt University · R01 · FY2016 · GM

Signal Integration of Transcriptional Pathways in Gliomagenesis

$335,545
Suyun Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Novel Targeted Therapeutics for Cental Nervous System Malignancies

$335,460
Francis Ali-Osman · Duke University · R01 · FY2009 · CA

Role of TEMs in brain tumor dispersal

$335,325
Candelaria Gomez-Manzano · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · NS

Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.

$335,203
Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2025 · CA

LuIII parvovirus targets glioma

$335,123
Anthony N Van Den Pol · Yale University · R01 · FY2014 · CA

Targeted Alpha-Particle Radiotheraphy of Brain Tumors with 211At-81C6 Antibody

$335,001
Michael Rod Zalutsky · Duke University · P50 · FY2015 · CA

Role of mTORC2 in GBM - development of a novel therapeutic mTOR kinase inhibitor

$334,921
Paul S Mischel · Ludwig Institute For Cancer Res Ltd · R01 · FY2012 · NS

Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells

$334,911
Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2018 · CA

Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme

$334,857
Todd A Waldman · Georgetown University · R01 · FY2012 · CA

Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence

$334,827
Atsuo Sasaki · University Of Cincinnati · R01 · FY2016 · NS

In vivo imaging of encapsulated stem cells in mouse models of tumor resection

$334,659
Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2017 · CA

In vivo imaging of encapsulated stem cells in mouse models of tumor resection

$334,659
Khalid A Shah · Massachusetts General Hospital · R01 · FY2013 · CA

High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment

$334,484
Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2017 · CA

Molecular Motors and Glioma Dispersion

$334,407
Steven S Rosenfeld · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · NS

Novel multipronged Immunovirotherapy Approach for GBM Treatment

$334,372
Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2025 · CA